![Paul Titley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Titley
Keine laufenden Positionen mehr
Profil
Paul Titley is the founder of Aesica Formulation Development Ltd., which was founded in 2006.
He was the Chief Executive Officer from 2010 to 2014.
Mr. Titley's former jobs include being a Non-Executive Director at N4 Pharma Ltd., an Executive Director at N4 Pharma Plc, and a Principal at Quintiles, Inc. (California) and Wellcome Plc.
Ehemalige bekannte Positionen von Paul Titley
Unternehmen | Position | Ende |
---|---|---|
N4 PHARMA PLC | Direktor/Vorstandsmitglied | 21.05.2019 |
Aesica Formulation Development Ltd.
![]() Aesica Formulation Development Ltd. Pharmaceuticals: MajorHealth Technology Aesica Formulation Development Ltd. develops pharmaceutical products. It offers sterile and nutraceutical product development and drug delivery services. The company was founded on December 22, 2005 and is headquartered in Northumberland, the United Kingdom. | Vorstandsvorsitzender | 22.11.2014 |
N4 Pharma Ltd.
![]() N4 Pharma Ltd. Pharmaceuticals: GenericHealth Technology N4 Pharma Ltd. operates as a drug reformulation company. The firm focuses on developing and out licensing new versions of existing and novel high value drugs with an unmet commercial or medical need. Its proprietary platform technologies include: Cocrys which is a process able to use hot melt extrusion to produce co-crystals of drugs; and Nuvac which is a nano-carrier delivery system for antigens that improves both humoral and cell mediation effects for vaccines. The company was founded by Nigel James Theobald in 2014 and is headquartered in Chellaston, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Wellcome Plc
![]() Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The company is based in Greenford, UK. | Corporate Officer/Principal | - |
Quintiles, Inc. (California)
![]() Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
N4 PHARMA PLC | Health Technology |
Private Unternehmen | 4 |
---|---|
Quintiles, Inc. (California)
![]() Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
Wellcome Plc
![]() Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The company is based in Greenford, UK. | Commercial Services |
Aesica Formulation Development Ltd.
![]() Aesica Formulation Development Ltd. Pharmaceuticals: MajorHealth Technology Aesica Formulation Development Ltd. develops pharmaceutical products. It offers sterile and nutraceutical product development and drug delivery services. The company was founded on December 22, 2005 and is headquartered in Northumberland, the United Kingdom. | Health Technology |
N4 Pharma Ltd.
![]() N4 Pharma Ltd. Pharmaceuticals: GenericHealth Technology N4 Pharma Ltd. operates as a drug reformulation company. The firm focuses on developing and out licensing new versions of existing and novel high value drugs with an unmet commercial or medical need. Its proprietary platform technologies include: Cocrys which is a process able to use hot melt extrusion to produce co-crystals of drugs; and Nuvac which is a nano-carrier delivery system for antigens that improves both humoral and cell mediation effects for vaccines. The company was founded by Nigel James Theobald in 2014 and is headquartered in Chellaston, the United Kingdom. | Health Technology |